Literature DB >> 24714726

Population- and type-specific clustering of multiple HPV types across diverse risk populations in the Netherlands.

Madelief Mollers, Henrike J Vriend, Marianne A B van der Sande, Jan E A M van Bergen, Audrey J King, Charlotte H Lenselink, Ruud L M Bekkers, Chris J L M Meijer, Hester E de Melker, Johannes A Bogaards.   

Abstract

In view of possible type replacement upon introduction of human papillomavirus (HPV) vaccination, we aimed to explore patterns of type-specific clustering across populations with various background infection risks. A total of 3,874 women from 3 cross-sectional studies in the Netherlands (in 2007-2009) provided vaginal self-samples, which were tested for 25 HPV genotypes by a sensitive molecular assay (SPF10 line probe assay, DDL Diagnostic Laboratory, Voorburg, the Netherlands). The number of concurrent HPV infections per woman was studied by Poisson regression. Associations between HPV types were investigated by generalized estimating equation analyses. The prevalence of any HPV type was 14% in a population-based study, 54% in a chlamydia screening intervention study, and 73% in a study among attendees of sexually transmitted infection clinics. Overall, multiple HPV infections were detected in 26% of the women. The number of concurrent HPV infections conformed to an overdispersed Poisson distribution, even after correction for known risk factors. Types differed significantly in their tendencies to be involved in coinfections, but no evidence for particular type-type interactions was found. Moreover, the strongest associations were observed in the lowest-risk population and vice versa.We found no indications of pairwise interactions, but our findings do suggest that clustering differs among HPV types and varies across risk groups.

Entities:  

Keywords:  antagonism; coinfection; human papillomavirus; monitoring; multilevel analysis; synergism; type replacement; vaccination

Mesh:

Year:  2014        PMID: 24714726     DOI: 10.1093/aje/kwu038

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.

Authors:  Talía Malagón; Philippe Lemieux-Mellouki; Jean-François Laprise; Marc Brisson
Journal:  Am J Epidemiol       Date:  2016-12-07       Impact factor: 4.897

2.  Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014.

Authors:  Rayleen M Lewis; Lauri E Markowitz; Julia W Gargano; Martin Steinau; Elizabeth R Unger
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

3.  Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination.

Authors:  Mahboobeh Safaeian; Ana Cecilia Rodriguez
Journal:  Am J Epidemiol       Date:  2014-10-29       Impact factor: 4.897

4.  Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination.

Authors:  Irene Man; Kari Auranen; Jacco Wallinga; Johannes A Bogaards
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

5.  Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.

Authors:  Joseph E Tota; Mengzhu Jiang; Agnihotram V Ramanakumar; Stephen D Walter; Jay S Kaufman; François Coutlée; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie Hélène Mayrand; Luisa L Villa; Eduardo L Franco
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

6.  Concurrent Infection With Multiple Human Papillomavirus Types Among Unvaccinated and Vaccinated 17-Year-Old Norwegian Girls.

Authors:  Ida Laake; Berit Feiring; Christine Monceyron Jonassen; John H O Pettersson; Torstein Gjølgali Frengen; Ingerid Ørjansen Kirkeleite; Lill Trogstad
Journal:  J Infect Dis       Date:  2022-09-04       Impact factor: 7.759

7.  Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer.

Authors:  Arsenio Spinillo; Mattia Dominoni; Anna C Boschi; Cecilia Sosso; Giacomo Fiandrino; Stefania Cesari; Barbara Gardella
Journal:  J Oncol       Date:  2020-10-26       Impact factor: 4.375

8.  Human Papillomavirus Distribution in Women with Abnormal Pap Smear and/or Cervical Intraepithelial Neoplasia in Vaccination Era. A Single-Center Study in the North Italian Population.

Authors:  Barbara Gardella; Mattia Dominoni; Cecilia Sosso; Anna Arrigo; Andrea Gritti; Stefania Cesari; Giacomo Fiandrino; Arsenio Spinillo
Journal:  Microorganisms       Date:  2021-03-31

9.  Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.

Authors:  Joske Hoes; Petra J Woestenberg; Johannes A Bogaards; Audrey J King; Hester E de Melker; Johannes Berkhof; Christian J P A Hoebe; Marianne A B van der Sande; Birgit H B van Benthem
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.